Physician profile
Cynthia King
NPI 1184750515
$697.22
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $33.10 · 2021: $21.99 · 2022: $4.72.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $165.07 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.23 | 2019 | |
| Smith+Nephew, INC. | $78.30 | 2019 | |
| Aspira Women'S Health INC | $66.44 | 2019 | |
| Allergan, INC. | $61.94 | 2019-2020 | |
| Avion Pharmaceuticals | $46.12 | 2019-2020 | |
| Daiichi Sankyo INC. | $37.57 | 2019 | |
| Vertical Pharmaceuticals, LLC | $35.61 | 2019 | |
| Duchesnay USA Incorporated | $24.54 | 2019 | |
| Exeltis, USA INC. | $22.08 | 2019 | |
| Therapeuticsmd, INC. | $21.99 | 2021 | |
| Sage Therapeutics, LLC | $20.55 | 2019 | |
| Merck Sharp & Dohme LLC | $15.78 | 2019 | |
| Coopersurgical, INC. | $15.28 | 2019 | |
| Organon LLC | $4.72 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.